Shift-Work Sleep Disorder
18
1
1
10
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 64/100
27.8%
5 terminated out of 18 trials
66.7%
-19.8% vs benchmark
11%
2 trials in Phase 3/4
50%
5 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (18)
Sleep and Circadian Treatments for Shift Workers
Biomarkers for Circadian Timing in Healthy Adults
Breath Biomarkers for Sleep Loss and Circadian Timing
The Effects of Lemborexant on the Ability to Sleep During Daytime
Shift Work and Risk of Cardio-vascular Disease
Health Promoting Work Schedules: The Effect of Abolishing Quick Returns
Transcranial Direct Current Stimulation Therapy for Sleepiness Related to Shift Work Disorder (tDCS-SWORD)
Light Treatment to Shift-working Nurses
Well-Being in Medical Residents in the HIBA
Biological Rhythms Impact of 12 Hours Shift Work
Effects of Daytime Eszopiclone Administration in Shift Workers
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Cardiometabolic Risk of Shiftwork
Assessments in Stress and Quality of Sleep/Life in Night-shift Nurses and Doctors
Fire Fighter Fatigue Management Program: Operation Fight Fatigue
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Sleep Enhancement Training Study for Novice Shiftworkers
Sleep Enhancement Training Study for Experienced Shiftworkers